The CRISPR/Cas9 gene editing system provides a precise, relatively simple and versatile method for editing DNA and, as such, has been hailed as the biggest biotech breakthrough of the 21st century. However, the European Patent Office (EPO) has now revoked one of the key, early patents...

The Federal Court of Australia in Mylan Health Pty Ltd v Sun Pharma ANZ Pty Ltd [2019] FCA 28 has considered whether a generic manufacturer of a pharmaceutical product sold under a “skinny label” could be liable for indirect infringement of a patent. In this...

New Zealand has implemented a 12-month grace period for disclosures of an invention that occur on or after 30 December 2018. Australia has had a grace period since 2002. Perhaps surprisingly, given the moves to harmonise procedures in the two countries and the creation of...

Translate »